Internal Medicine, Rheumatology · Seattle, WA
NPI
1124215033
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
904 7th Ave
Seattle, WA, 98104
Phone (206) 860-2383
Groups this clinician bills Medicare through
Medicare paid, 2024
$163K
6,970 services
Medicare patients, 2024
297
Average age 76
Drug cost, 2024
$2.8M
2,339 prescriptions
Company payments, 2025
$4,513
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony M Krajcer was code J0897 (injection, denosumab, 1 mg), 1,740 times for 20 patients. In total Anthony M Krajcer billed 6,970 services in 71 codes, and Medicare paid $163K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 20 | $20.35 | $35K |
| 99214 Office E&M - Established | Office | 692 | 264 | $100.40 | $69K |
| 36415 Venipuncture Blood Collection | Office | 558 | 237 | $8.62 | $4,811 |
| 85652 Clinical Chemistry | Office | 532 | 215 | $2.64 | $1,405 |
| 85025 Blood Count | Office | 511 | 204 | $7.60 | $3,881 |
| 80053 Clinical Chemistry | Office | 491 | 202 | $10.33 | $5,072 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 479 | 231 | $13.39 | $6,414 |
| 86140 Clinical Chemistry | Office | 468 | 184 | $5.06 | $2,368 |
| 86160 Immunoassay | Office | 178 | 54 | $11.76 | $2,093 |
| 81001 Clinical Chemistry | Office | 92 | 53 | $3.11 | $286 |
| 82306 Clinical Chemistry | Office | 77 | 64 | $29.01 | $2,234 |
| 80048 Clinical Chemistry | Office | 40 | 32 | $8.29 | $332 |
| 84550 Clinical Chemistry | Office | 37 | 24 | $4.43 | $164 |
| 96372 Injection Administration | Office | 34 | 25 | $12.77 | $434 |
| 99204 Office E&M - New | Office | 30 | 30 | $134.42 | $4,033 |
By year: 2022 $605K for 42,424 services; 2023 $159K for 6,899 services; 2024 $163K for 6,970 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 558 | 237 | $8.62 | $4,811 |
| 85652 Clinical Chemistry | 532 | 215 | $2.64 | $1,405 |
| 85025 Blood Count | 511 | 204 | $7.60 | $3,881 |
| 80053 Clinical Chemistry | 491 | 202 | $10.33 | $5,072 |
| 86140 Clinical Chemistry | 468 | 184 | $5.06 | $2,368 |
| 86160 Immunoassay | 178 | 54 | $11.76 | $2,093 |
| 81001 Clinical Chemistry | 92 | 53 | $3.11 | $286 |
| 82306 Clinical Chemistry | 77 | 64 | $29.01 | $2,234 |
| 80048 Clinical Chemistry | 40 | 32 | $8.29 | $332 |
| 84550 Clinical Chemistry | 37 | 24 | $4.43 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug Anthony M Krajcer prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 278 prescriptions and refills. In total Anthony M Krajcer wrote 2,339 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 278 | 713 | 90 | $10K |
| Prednisone Generic | 273 | 470 | 88 | $2,392 |
| Methotrexate Methotrexate Sodium | 229 | 440 | 56 | $4,892 |
| Tramadol Hcl Generic | 131 | 133 | 24 | $1,354 |
| Gabapentin Generic | 92 | 175 | 31 | $1,021 |
| Celecoxib Generic | 73 | 115 | 24 | $999 |
| Allopurinol Generic | 72 | 211 | 23 | $1,115 |
| Humira(Cf) Pen Adalimumab | 64 | 71 | Under 11 | $539K |
| Alendronate Sodium Generic | 63 | 153 | 21 | $588 |
| Sulfasalazine Dr Sulfasalazine | 54 | 113 | 12 | $1,888 |
| Diclofenac Sodium Generic | 52 | 52 | 18 | $1,830 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 51 | 51 | Under 11 | $410K |
| Sulfasalazine Generic | 49 | 75 | 12 | $1,533 |
| Leflunomide Generic | 48 | 94 | 13 | $1,076 |
| Folic Acid Generic | 46 | 139 | 15 | $573 |
Brand drugs: - claims; generic drugs: 1,793 claims; opioid claims: 200.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony M Krajcer $4,513 ($4,513 in general payments such as food, travel and fees) from 7 companies. The largest payer was Janssen Biotech, Inc. with $2,335.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.